Lindbrook Capital LLC Increases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Lindbrook Capital LLC lifted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 18.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 246 shares of the biotechnology company’s stock after buying an additional 38 shares during the quarter. Lindbrook Capital LLC’s holdings in Axon Enterprise were worth $146,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of AXON. Farther Finance Advisors LLC lifted its holdings in shares of Axon Enterprise by 19.4% in the third quarter. Farther Finance Advisors LLC now owns 875 shares of the biotechnology company’s stock worth $350,000 after buying an additional 142 shares in the last quarter. Advisor Resource Council purchased a new stake in shares of Axon Enterprise in the third quarter worth about $270,000. Principal Financial Group Inc. lifted its holdings in shares of Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after buying an additional 33,869 shares in the last quarter. SpiderRock Advisors LLC increased its position in shares of Axon Enterprise by 2.6% in the third quarter. SpiderRock Advisors LLC now owns 2,325 shares of the biotechnology company’s stock worth $929,000 after purchasing an additional 58 shares during the last quarter. Finally, Assetmark Inc. increased its position in shares of Axon Enterprise by 4.2% in the third quarter. Assetmark Inc. now owns 5,315 shares of the biotechnology company’s stock worth $2,124,000 after purchasing an additional 214 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,146 shares of company stock worth $3,262,847 over the last three months. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

AXON has been the topic of several research analyst reports. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays set a $726.00 price objective on Axon Enterprise and gave the company an “overweight” rating in a research note on Thursday, February 27th. The Goldman Sachs Group raised their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Finally, Northland Securities raised their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $526.40 on Friday. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a fifty day moving average price of $601.11 and a 200-day moving average price of $527.38. The company has a market capitalization of $40.14 billion, a PE ratio of 136.02, a PEG ratio of 5.17 and a beta of 1.12.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.